The Early Signs and Symptoms of Psoriatic Arthritis: The Importance of Early Evaluation and Treatment

Cuellar M.L. , Silveira L.H. , Espinoza L.R. Recent developments in psoriatic arthritis. Curr Opin Rheumatol. 1994 Jul; 6(4): 378–84.

Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003; 4: 441–7.

Klippel J.H. “Primer of the Rheumatic Diseases,” 11th ed. 1997 Atlanta 175–179.

Gladman D.D. , Antoni C. , Mease P. , Clegg D.O. , Nash P. Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis. 2005; 64(Suppl II): ii14–ii17.

Moll J.M. , Wright V. Psoriatic Arthritis. Semin Arthritis Rheum. 1973; 3: 55–78.

Roberts M.E. , Wright V. , Hill AG , Mehra A.C. Psoriatic Arthritis. Follow-up study. Ann Rheum Dis. 1976; 35: 206–12.

Kammer G.M. , Soter N.A. , Gibson D.J. , Schur P.H. Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum. 1979; 9: 75–97.

Torre-Alonso J.C. , Rodriguez Perez A. , Arribas Castrillo J.M. Psoriatic arthritis (PA): a clinical, immunological and radiological study. Br J Rheumatol. 1991; 30: 245–50.

Veale D. , Rogers S. , Fitzgerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol. 1994; 33: 133–8.

Trabace S. , Cappellacci S. , Ciccarone P. Psoriatic arthritis: a clinical radiological and genetic study of 58 Italian patients. Acta Derm Venereol Suppl (Stockh). 1994; 186: 69–70.

Scarpa R. , Oriente P. , Pucino A. Psoriatic arthritis in psoriatic patients. Br J Rheumatol. 1984; 23: 246–50.

Gladman D.D. , Shuckett R. , Russell M.L. , Thorne J.C. , Schachter R.K. Psoriatic arthritis (PSA)—an analysis of 220 patients. Q J Med. 1987; 62: 127–41.

Helliwell P. , Marchesoni A. , Peters M. , Barker M. , Wright V. A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol. 1991; 30: 339–45.

Jones S.M. , Armas J.B. , Cohen M.G. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol. 1994; 33: 834–9.

Marsal S. , Armadans-Gil L. , Martinez M. Clinical, radiographic, and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford). 1999; 38: 332–7.

Kane D. , Stafford L. , Bresnihan B. , and Fitzgerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheum. 2003; 42: 1460–1468.

Mease P. , Krivitz A. , Burch F. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum. 2004; 50: 2264–2272.

Antoni C. , Krueger G.G. , de Vlam K. , Birbara C. , Beutler A. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis. (online) 24 Feb 2005: 1–8.

Van der Heijde D. , Kavanaugh A. , Beutler A. , Guzzo C. , Zhou B. , Dooley L. , Antoni C. E. , Krueger G. G. , Gladman D. Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis: results from impact 2 trial. European Congress of Rheumatology, Vienna, Austria, June 2005.

Kraan M.C. , van Kujik A.W.R. , Dinant H.J. , Goedkoop A.Y. , Smeets T.J.M. Alefacept treatment in psoriatic arthritis. Reduction of effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis. Arthritis Rheum 2002; 46: 2776–84.

Menter A. , Lebwohl M. Alefacept in Combination with Methotrexate for the Treatment of Psoriatic Arthritis: Preliminary Results from a Randomized, Double-Blind, Placebo-controlled Study. American Academy of Dermatology. New Orleans. February 2005.

Mease P.J. , Sharp J.T. , Ory P. Adalimumab Treatment Effects on Radiographic Progression of Joint Disease in Patients with Psoriatic Arthritis: Results from ADEPT. European Congress of Rheumatology, Vienna, Austria, June 2005.